Immunexpress Belgium BV
Immunexpress Belgium (BV) is a company in Leuven, active in wholesale of pharmaceutical and medical goods, founded in 2024. Financial year 2025: gross margin -€219,454, profit -€305,459, equity -€295,459.
1 warning: negative equity1 seriousShowHide
- Explained →
Negative equity. Equity was € -295,459 in financial year 2025. Debts exceed what the company owns; the board must in principle follow the alarm bell procedure.
Source: NBB, 2025 annual accounts
Figures for Immunexpress Belgium, 2025NBB · abridged format
All figures, sector and health →Three ratios
How we calculateAnnual accounts 2025. The sector is recalculated every night.
See everything about Immunexpress Belgium
Health check, financial year in detail, 10 years of history and the board.
What happenedfrom the annual accounts and the CBE
- Annual accounts 2025 filed
- Incorporated as besloten vennootschap
Activities NACE-BEL 2025
46.460Wholesale of pharmaceutical and medical goodsMain activity26.510Manufacture of instruments and appliances for measuring, testing and navigation32.500Manufacture of medical and dental instruments and supplies68.201Rental and operating of own or leased real estate68.203Rental and operating of own or leased real estate72.101Research and experimental development on natural sciences and engineering
Establishments 1
- Vaartdijk 59/2, 3018 Leuven · since 16/07/20242.362.046.703
Publications in the Belgian Official Gazette 1 publication
- 18/07/2024Incorporation and articlesOprichting (nieuwe rechtspersoon, opening bijkantoor, enz...)Deed (pdf)
To the publication → list, timeline or per year
E-invoicing and VAT
Checking… · Peppol network and European VAT register (VIES)Read more